{
    "nct_id": "NCT04701333",
    "official_title": "Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss",
    "inclusion_criteria": "* Pregnant people, ages 18 years or older\n* Intrauterine pregnancy between 18/0-28/0 weeks of gestation age (by ultrasound dating performed prior to or same day of enrollment visit)\n* Consented for an induced, elective abortion or undergoing induction for demise\n* English or Spanish speaking\n* Able to consent for a research study, literate in English or Spanish\n* Willing to comply with study procedures and follow-up\n* Access to smart phone throughout study\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior mastectomy (breast reduction or chest masculinization surgery acceptable)\n* Currently breastfeeding\n* Currently receiving dopamine agonist therapy for other indication (prolactinoma, Cushings syndrome, acromegaly, restless leg syndrome)\n* Contraindication to cabergoline (as per package insert)\n\n  * Uncontrolled hypertension - defined as baseline BP > 150/100, or chronic hypertension requiring more than one baseline medication, or pregnancy-induced hypertension spectrum disorders (gestational hypertension, preeclampsia, eclampsia)\n  * History of cardiac valvular disorders or valvular repair\n  * History of pulmonary, pericardial, or retroperitoneal fibrotic disorders",
    "miscellaneous_criteria": ""
}